ATE225368T1 - Verfahren zur reinigung von faktor viii - Google Patents

Verfahren zur reinigung von faktor viii

Info

Publication number
ATE225368T1
ATE225368T1 AT95937285T AT95937285T ATE225368T1 AT E225368 T1 ATE225368 T1 AT E225368T1 AT 95937285 T AT95937285 T AT 95937285T AT 95937285 T AT95937285 T AT 95937285T AT E225368 T1 ATE225368 T1 AT E225368T1
Authority
AT
Austria
Prior art keywords
factor viii
aqueous solution
pct
gel
present
Prior art date
Application number
AT95937285T
Other languages
English (en)
Inventor
Anna-Lisa Smeds
Original Assignee
Inst Genetics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Genetics Llc filed Critical Inst Genetics Llc
Application granted granted Critical
Publication of ATE225368T1 publication Critical patent/ATE225368T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Liquid Crystal Substances (AREA)
  • Steroid Compounds (AREA)
AT95937285T 1994-11-14 1995-11-14 Verfahren zur reinigung von faktor viii ATE225368T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9403914A SE503424C2 (sv) 1994-11-14 1994-11-14 Process för rening av rekombinant koagulationsfaktor VIII
PCT/SE1995/001350 WO1996015140A1 (en) 1994-11-14 1995-11-14 Process for purification of factor viii

Publications (1)

Publication Number Publication Date
ATE225368T1 true ATE225368T1 (de) 2002-10-15

Family

ID=20395963

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95937285T ATE225368T1 (de) 1994-11-14 1995-11-14 Verfahren zur reinigung von faktor viii

Country Status (13)

Country Link
US (1) US6005082A (de)
EP (1) EP0792281B1 (de)
JP (1) JP3871710B2 (de)
AT (1) ATE225368T1 (de)
AU (1) AU691993B2 (de)
CA (1) CA2202873C (de)
DE (1) DE69528471T2 (de)
DK (1) DK0792281T3 (de)
ES (1) ES2182915T3 (de)
NZ (1) NZ295810A (de)
PT (1) PT792281E (de)
SE (1) SE503424C2 (de)
WO (1) WO1996015140A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1820516B1 (de) 1999-02-22 2013-07-24 University of Connecticut Neue albuminfreie Faktor VIII Formulierungen
US6822081B2 (en) * 2000-01-13 2004-11-23 Max-Planck Gesellschaft zur Förderung der Wissenschaften e.V. Process for the isolation and/or purification of a proteinaceous material
EP1681299B1 (de) 2000-03-27 2009-11-11 Genetics Institute, LLC Verfahren zur Reinigung stark anionischer Proteine
EP1404428B1 (de) * 2001-06-05 2006-07-19 Genetics Institute, LLC Verfahren zur reinigung hochanionischer proteine
US7427659B2 (en) * 2003-10-24 2008-09-23 Amgen Inc. Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction
BRPI0814220B8 (pt) * 2007-07-11 2021-05-25 Novo Nordisk As purificação de fator viii usando uma resina multimodal ou de modo misto
EP2385825B1 (de) 2008-11-07 2018-10-10 University of Connecticut Faktor-viii-formulierungen
CA2771999A1 (en) 2009-08-24 2011-03-10 Amunix Operating Inc. Coagulation factor vii compositions and methods of making and using same
KR20130020789A (ko) 2010-05-19 2013-02-28 에프. 호프만-라 로슈 아게 소수성 상호작용 크로마토그래피 방법
EP2652491B1 (de) 2010-12-15 2017-11-29 Baxalta GmbH Eluatsammlung mit leitfähigkeitsgradient
BRPI1105317A2 (pt) 2011-01-24 2013-04-30 Fundacco Hemoct De Ribeirco Preto produÇço estÁvel e em larga escala de fviii humano em linhagem celular humana sk-hep-1
WO2012149197A2 (en) 2011-04-27 2012-11-01 Abbott Laboratories Methods for controlling the galactosylation profile of recombinantly-expressed proteins
CN111548418A (zh) 2012-02-15 2020-08-18 比奥贝拉蒂治疗公司 因子viii组合物及其制备和使用方法
WO2013123457A1 (en) 2012-02-15 2013-08-22 Biogen Idec Ma Inc. Recombinant factor viii proteins
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
SG11201507230PA (en) 2013-03-12 2015-10-29 Abbvie Inc Human antibodies that bind human tnf-alpha and methods of preparing the same
US10023608B1 (en) 2013-03-13 2018-07-17 Amgen Inc. Protein purification methods to remove impurities
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
US10548953B2 (en) 2013-08-14 2020-02-04 Bioverativ Therapeutics Inc. Factor VIII-XTEN fusions and uses thereof
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
EA201691111A1 (ru) 2014-01-10 2017-01-30 Байоджен Ма Инк. Химерные белки фактора viii и их применение
UA126016C2 (uk) 2015-08-03 2022-08-03 Біовератів Терапеутікс Інк. Злитий білок фактора іх
KR20190090827A (ko) 2016-12-02 2019-08-02 바이오버라티브 테라퓨틱스 인크. 키메라 응고 인자를 사용해 혈우병성 관절증을 치료하는 방법
EP3642225A1 (de) * 2017-06-23 2020-04-29 Baxalta Incorporated Reinigung von faktor viii-subspezies
KR102914074B1 (ko) 2018-05-18 2026-01-16 바이오버라티브 테라퓨틱스 인크. A형 혈우병의 치료 방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74909A (en) * 1984-04-20 1992-01-15 Genentech Inc Preparation of functional human factor viii and dna sequences,expression vectors,transformed microorganisms and cell lines used therein
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
SE8501050D0 (sv) * 1985-03-05 1985-03-05 Kabivitrum Ab Biologically active fragments of human antihemophilic factor and method for preparation thereof
US4758657A (en) * 1985-07-11 1988-07-19 Armour Pharmaceutical Company Method of purifying Factor VIII:C
US5595886A (en) * 1986-01-27 1997-01-21 Chiron Corporation Protein complexes having Factor VIII:C activity and production thereof
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
SE465222C5 (sv) * 1989-12-15 1998-02-10 Pharmacia & Upjohn Ab Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
FR2662166A1 (fr) * 1990-05-18 1991-11-22 Fondation Nale Transfusion San Procede de preparation de facteur viii de tres haute purete comprenant une etape rapide d'immunoadsorption.
GB9211538D0 (en) * 1992-06-01 1992-07-15 Blake David R Antiinflammatory agent
ATE198277T1 (de) * 1992-10-02 2001-01-15 Genetics Inst Zusammensetzung, welche den koagulationsfaktor viii beinhaltet; verfahren zu deren herstellung und die benutzung eines oberflächenaktiven stoffes als stabilisator
EP0674531A1 (de) * 1992-12-16 1995-10-04 IMMUNO Aktiengesellschaft Verfahren zur herstellung eines virussicheren biologischen präparates

Also Published As

Publication number Publication date
JP3871710B2 (ja) 2007-01-24
PT792281E (pt) 2003-02-28
EP0792281B1 (de) 2002-10-02
NZ295810A (en) 1998-08-26
AU691993B2 (en) 1998-05-28
EP0792281A1 (de) 1997-09-03
MX9703470A (es) 1997-07-31
DK0792281T3 (da) 2003-02-03
CA2202873A1 (en) 1996-05-23
SE9403914L (sv) 1996-05-15
CA2202873C (en) 2011-06-21
JPH10508841A (ja) 1998-09-02
DE69528471D1 (de) 2002-11-07
AU3943895A (en) 1996-06-06
US6005082A (en) 1999-12-21
WO1996015140A1 (en) 1996-05-23
SE503424C2 (sv) 1996-06-10
SE9403914D0 (sv) 1994-11-14
ES2182915T3 (es) 2003-03-16
DE69528471T2 (de) 2003-07-10

Similar Documents

Publication Publication Date Title
DE69528471D1 (de) Verfahren zur reinigung von faktor viii
DE4435485C1 (de) Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor
DE3486423T3 (de) Neue Faktor VIII Polypeptidkoagulantien
DE359593T1 (de) Chromatographische trennung von plasmaproteinen.
ES2174957T3 (es) Proteinas purificadas de envoltura de virus de la hepatitis c para uso diagnostico y terapeutico.
KR860008276A (ko) 단백질이 생성된 배양기로 부터 그것을 추출, 정제하는 방법
EP0077870A2 (de) Verfahren zur Wärmebehandlung einer den menschlichen Blutgerinnungsfaktor VIII enthaltenden wässrigen Lösung
MX9703552A (es) Proceso de purificacion de factor viii.
EP0202853A2 (de) Die Wirksamkeit des Hemmstoffes vom Faktor VIII neutralisierendes Polypeptid und dieses enthaltende therapeutische Zusammensetzung
EP0567448B1 (de) Verfahren zur Herstellung von Faktor VIII
JPH0381290A (ja) 精製されたアルブミン溶液の製造方法
JPH0545600B2 (de)
DE3584775D1 (de) Zusammensetzung zur behandlung von an haemophilia-a-inhibitor leidenden kranken.
EP0117064A2 (de) Verfahren zur Hitzebehandlung vom Blutgerinnungsfaktor VIII
AT396937B (de) Verfahren zur aktivierung von blutgerinnungsfaktoren
DE69738397D1 (de) Verfahren zur aufreinigung von apolipoprotein-a oder apolipoprotein-e aus menschlichem plasma
ATE190492T1 (de) Verwendung von gift aus hautflüglern (hymenopteren) zur herstellung eines medikamentes zur behandlung von infektionen durch dna-viren
ATE356145T1 (de) Polypeptide zur regenerierung des nervensystems
ATE263779T1 (de) Wässrige proteinzusammensetzung, enthaltende glykoproteine, verfahren zur herstellung und verwendungen
AT407750B (de) Verfahren zur herstellung einer vwf-präparation
US4769336A (en) Treatment of factor VIII inhibitors
CA1301680C (en) Process of preparing physiologically active proteinaceous solutions
JP2678193B2 (ja) ヒト血漿由来血液凝固第ｘ▲ｉｉｉ▼因子の製造方法
KR910016339A (ko) Pp4-델타, 이의 제조방법 및 용도
DK563886A (da) Terapeutisk komposition

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0792281

Country of ref document: EP